A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis: comment on the article by Maksymowych et al
- Maksymowych, Walter P. FRCP(C)
- Russell, Anthony S. FRCP(C)
Arthritis & Rheumatism 48(2):p 584, February 2003.
Copyright © 2003, American College of Rheumatology